LYEL Competitors & Alternatives
Compare Lyell Immunopharma Inc with similar stocks in the same industry
Biotechnology
LYEL
Main Stock$14.82
Tradestie Score
32
Market Cap
$317.95M
Revenue Growth
-0.5%
Analyst Upside
+155.6%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$76.75
|
$410.79M | - | 46 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$14.42
|
$407.71M | - | 34 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$15.21
|
$386.68M | - | 33 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.69
|
$382.04M | - | 47 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.60
|
$371.64M | - | 38 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$21.63
|
$354.45M | - | 31 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$48.09
|
$353.70M | - | 42 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.60
|
$350.98M | - | 53 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.08
|
$341.56M | - | 42 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.91
|
$332.96M | - | 42 | Compare |
More LYEL Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry